Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preinvasive cervical neoplasia

K D Hatch1

  • 1Division of Gynecologic Oncology, Obstetrics and Gynecology, University of Arizona, Tucson 85724.

Seminars in Oncology
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Human Papillomavirus (HPV) causes cervical neoplasia by inactivating tumor suppressor proteins. However, co-factors are crucial for cancer development, prompting further investigation into their role.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrosurgical Excision Procedures: LLETZ and LEEP-A Critical Analysis.

Journal of lower genital tract disease·2015
Same author

Response 2.

Journal of lower genital tract disease·2015
Same author

Chlamydia trachomatis and Pap testing from a single, fluid-based sample. A multicenter study.

The Journal of reproductive medicine·2001
Same author

Wilms' tumor of the cervix: a case report and review of the literature.

Gynecologic oncology·2000
Same author

In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.

Gynecologic oncology·1998
Same author

The role of operative laparoscopy to evaluate candidates for pelvic exenteration.

Gynecologic oncology·1998
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Human Papillomavirus (HPV) is the primary cause of cervical neoplasia.
  • HPV oncoproteins E6 and E7 inactivate tumor suppressor proteins p105Rb and p53, driving cellular transformation.
  • A low incidence of neoplasia despite high HPV prevalence suggests the involvement of co-factors.

Purpose of the Study:

  • To investigate the role of co-factors in HPV-induced cervical carcinogenesis.
  • To identify potential co-factors that contribute to the development of cervical neoplasia.

Main Methods:

  • The abstract does not specify methods, but implies a search for co-factors.
  • Research likely involves molecular and epidemiological approaches to identify contributing factors.

Related Experiment Videos

Main Results:

  • The abstract indicates that co-factors are essential for cervical carcinogenesis.
  • The specific co-factors have not yet been identified and are under investigation.

Conclusions:

  • Co-factors play a significant role in the progression from HPV infection to cervical neoplasia.
  • Further research is necessary to identify and characterize these co-factors to understand HPV carcinogenesis fully.